TickerSutra

NSE: PRAJIND · BSE: 522205 · ISIN INE074A01025

Praj Industries Limited stock analysis

Praj Industries Limited ranks #2746 in the TickerSutra evidence-ranked universe with a score of 44/100 and 95% data confidence. The latest captured fundamentals show ROCE of 6.1%, quarterly sales growth of 11.8% and quarterly profit growth of 117.4%.
Complete evidence gate pass governance reviewUpdated 29 Sept 2026
TICKERSUTRA SCORE44/100

Avoid / exit review

#2746 of 5,430 ranked equities
Market capitalisation₹6,217.41cr
ROCE6.1%
Quarterly sales growth11.8%
Quarterly profit growth117.4%
P/E ratio123.1×
Promoter pledge0.0%

INVESTMENT EVIDENCE

What supports—and challenges—the thesis

Evidence in favour

  • Low debt/equity of 0.13×
  • Strong CFO/EBITDA of 1.29×
  • CWIP indicates an active capacity pipeline
  • No promoter shares are reported as pledged

Risks and constraints

  • Operating margin has compressed materially
  • Valuation is above 40× earnings

Still unresolved: Related-party exposure · Broad media sentiment

FINANCIAL TRAJECTORY

Recent operating history

PeriodRevenueOperating profitNet profitOperating margin
2022₹2,343cr₹194cr₹150cr8.0%
2023₹3,528cr₹308cr₹240cr9.0%
2024₹3,466cr₹372cr₹283cr11.0%
2025₹3,228cr₹314cr₹219cr10.0%
2026₹3,168cr₹155cr₹24cr4.9%
TTM₹3,244cr₹150cr₹30cr4.6%
Debt / equity0.13×
CFO / EBITDA1.29×
Operating margin4.6%
Free cash flow₹157cr
Sales CAGR · 3Y-3.5%
Profit CAGR · 3Y-53.6%

EXCHANGE EVENT TRIGGERS

Latest corporate disclosures

0 positive catalysts0 negative catalysts0 routine filings
No current exchange announcement is mapped to this research snapshot.

MANAGEMENT COMMENTARY

Signals from filed documents

Margin expansionHigh severity · 1 mention
Positive catalyst

I would like to explain it to you in little bit detail so that everyone will get benefited. This quarter, we have seen 3% margin improvement only on the material cost. But at the same time, if you look at my other expenses have gone up by 4%.

Pricing commentaryHigh severity · 1 mention
Constructive

These co-products find applications in sectors such as animal nutrition, food ingredients, and industrial applications, thereby improving overall plant profitability. By enabling integrated processing and maximizing output from the same input, co-product valorization plays a critical role in margin enhancement and risk diversification, particularly in a dynamic pricing environment for biofuels. During the year, Praj

Capacity expansion plansHigh severity · 12 mentions
Positive catalyst

We believe that this situation will continue till the time we see policies around higher blending mandates. While greenfield projects are moving slowly, we see increasing demand for our Brownfield solutions, where customers are prioritizing operational efficiency improvements and value -added co -products, such as the Distillers corn oil or DCO. There is a strong demand for greenfield ENA plants, where Praj has a cle

Management confidenceModerate severity · 1 mention
Constructive

The journey to 2030 will demand agility, innovation, and collaboration. With a strong foundation, talented people, differentiated technologies, and the trust of our stakeholders, we are confident of achieving our aspirations while creating lasting value for society and our shareholders. I thank our customers, employees, partners, investors, and Board members for their unwavering support.

Export market updatesModerate severity · 7 mentions
Constructive

Just a 2% blending mandate for Bio -IBA in diesel has a potential to create over INR 3,000 crore project opportunity. In the international market, we have received an order for setting up a greenfield grain -to- ethanol plant in Brazil. This project will be a marquee reference for Praj in the region.

Regulatory updatesModerate severity · 24 mentions
Constructive

Praj remains focused on innovation, integrated execution, and long-term customer partnerships to capitalize on these opportunities. Water and wastewater treatment continues to play an increasingly important role in Praj’s engineering portfolio, driven by growing emphasis on sustainability, resource efficiency, and regulatory compliance across industries. During the year, the Company strengthened its capabilities acro

Regulatory approvalLow severity · 9 mentions
Watch

Incremental costs of obtaining a contract, if any, and costs incurred to fulfil a contract are amortised over the period of execution of the contract in proportion to the progress measured in terms of a proportion of actual cost incurred to-date, to the total estimated cost attributable to the performance obligation. Contract modification, when approved by both the parties to the contract, are considered as modificat

HOW TO READ THIS PAGE

Evidence, freshness and limitations

What does the TickerSutra score mean?

The score ranks captured evidence across financial quality, growth, moat and margins, regulatory catalysts, governance, institutional trend and valuation comfort. It is a research-prioritization tool—not a buy recommendation or price target.

Which sources support this page?

Financial history, ownership and pledge data, NSE and BSE filings, annual reports and available earnings-call transcripts are combined here. Use the source trail and original exchange document before relying on a decision-critical fact.

Why can an item be unresolved?

Unresolved means the current captured source window did not provide enough evidence for that check. It does not establish that a risk or relationship is absent.

Maintained by TickerSutra Research · Snapshot updated 29 Sept 2026 · Read the methodology · Read the disclaimer

DIRECTOR & BUSINESS NETWORK

Loading corporate intelligence

Loading universe coverage and exchange-backed evidence…